https://childrenshealthdefense.org/defender/merck-mumps-vaccine-false-labeling-antitrust-lawsuit/
Citing the Noerr-Pennington doctrine, a U.S. appeals court on Monday ruled that because the FDA took no action against Merck after discovering the false labeling claims, it was the FDA’s decision — not Merck’s fraud — that injured competitor GSK and the physicians and physicians groups who bought the ineffective vaccine at inflated prices.
by Brenda Baletti, Ph.D.
October 11, 2024
